LDLR and metabolic dysfunction-associated steatotic liver disease: In this study we have demonstrated that inhibition of adiposity and inhibition of DES1, the final step in ceramide biosynthesis, by FEN can prevent hepatic triglyceride accumulation and steatosis in the LDLR−/− mouse model of diet-induced NAFLD and atherosclerosis.